Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Shares Issued (2022 - 2025)

Lucid Diagnostics (LUCD) has disclosed Shares Issued for 4 consecutive years, with $27.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Issued changed N/A year-over-year to $27.0 million, compared with a TTM value of $43.2 million through Sep 2025, up 1079175.0%, and an annual FY2024 reading of $4000.0, down 99.78% over the prior year.
  • Shares Issued was $27.0 million for Q3 2025 at Lucid Diagnostics, up from $16.2 million in the prior quarter.
  • Across five years, Shares Issued topped out at $27.0 million in Q3 2025 and bottomed at -$1.1 million in Q2 2022.
  • Average Shares Issued over 4 years is $4.5 million, with a median of $235500.0 recorded in 2022.
  • The sharpest move saw Shares Issued soared 25166.67% in 2023, then tumbled 98.59% in 2024.
  • Year by year, Shares Issued stood at $1.1 million in 2022, then skyrocketed by 36.21% to $1.5 million in 2023, then crashed by 99.74% to $4000.0 in 2024, then soared by 674825.0% to $27.0 million in 2025.
  • Business Quant data shows Shares Issued for LUCD at $27.0 million in Q3 2025, $16.2 million in Q2 2025, and $3000.0 in Q1 2025.